glp 1 agonist vs sglt2 inhibitor GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Use of GLP-1 Receptor Agonists

Weight management can be influenced by many non-modifiable factors like genetic predispositions, age, and ethnicity

The first goal of these trials was to prove GLP-1 receptor agonists cardiovascular safety, and majority of CVOTs were designed as non-inferiority trials

The mechanism involves activation of AMPK pathways and improvement in mitochondrial function, which addresses metabolic dysfunction at a cellular level that GLP-1 agonists do not directly target

Greco EV, Russo G, Giandalia A, Viazzi F, Pontremoli R, De Cosmo S

Available from: 16

Glucagon acting at the GLP-1 receptor contributes to -cell regeneration induced by glucagon receptor antagonism in diabetic mice